Type 1 diabetes clinical trials

Explore recruiting type 1 diabetes clinical trials.

Recruiting type 1 diabetes studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Type 1 diabetes trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A GLP-1 receptor PET imaging add-on study within the VERA-T1D trial investigating the effects on beta cell mass (Image-VER-A-T1D)

Austria, France

Therapeutic exploratory (Phase II) EU CTIS Study details

Colchicine to reduce microvascular complications in people with type 1 diabetes and high glycemic variability

Netherlands

Phase III and phase IV (Integrated) EU CTIS Study details

Impact of Metformin on Peripheral Arterial Calcification in Type 1 Diabetes (IMPACT-1D)

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

The POST-PRANDIAL HYPO-AVOID STUDY Low-Dose Glucagon and Automated Insulin Delivery for Prevention of Spontaneous Exercise-Induced Hypoglycemia in People with Type 1 Diabetes

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

Tolerogenic dendritic cell therapy in type 1 diabetes; a phase 1b safety and immunological effecitivity study

Netherlands

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Anti-viral action against Type 1 diabetes autoimmunity GPPAD-05-AVAnT1A

Poland, Sweden, Belgium, Germany, Austria, Italy

Therapeutic use (Phase IV) EU CTIS Study details

Type 1 diabetes trials by city

Type 1 diabetes in Toronto Type 1 diabetes in Vancouver Type 1 diabetes in Montreal Type 1 diabetes in Calgary Type 1 diabetes in Edmonton Type 1 diabetes in Ottawa Type 1 diabetes in Winnipeg Type 1 diabetes in Quebec City Type 1 diabetes in Hamilton Type 1 diabetes in Kitchener Type 1 diabetes in London Type 1 diabetes in Halifax Type 1 diabetes in New York Type 1 diabetes in Los Angeles Type 1 diabetes in Chicago Type 1 diabetes in Houston

Other conditions

Obesity Type 2 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease IgA nephropathy